Royal Bank Of Canada Immuno Precise Antibodies Ltd. Transaction History

Royal Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 05, 2024	BUY	$1.4 - $2.41 $24,638 - $42,413	17,599 New	17,599 $26,000
Q1 2024 May 15, 2024	BUY	$1.4 - $2.41 $20,300 - $34,945	14,500 Added 467.89%	17,599 $26,000
Q3 2023 Nov 14, 2023	SELL	$1.76 - $3.04 $88 - $152	-50 Reduced 1.59%	3,099 $5,000
Q2 2023 Aug 14, 2023	SELL	$2.42 - $4.04 $63,331 - $105,726	-26,170 Reduced 89.26%	3,149 $9,000
Q1 2023 May 15, 2023	BUY	$2.77 - $5.49 $81,075 - $160,686	29,269 Added 58538.0%	29,319 $81,000
Q4 2022 Feb 14, 2023	SELL	$4.5 - $5.72 $1,125 - $1,430	-250 Reduced 83.33%	50 $0
Q1 2022 May 16, 2022	SELL	$3.64 - $6.49 $8,979 - $16,010	-2,467 Reduced 89.16%	300 $2,000
Q4 2021 Feb 14, 2022	SELL	$5.06 - $6.69 $4,270 - $5,646	-844 Reduced 23.37%	2,767 $15,000
Q3 2021 Nov 15, 2021	BUY	$5.14 - $13.22 $1,536 - $3,952	299 Added 9.03%	3,611 $22,000
Q2 2021 Aug 16, 2021	BUY	$6.02 - $12.91 $19,938 - $42,757	3,312 New	3,312 $20,000

1.9M

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $10.2M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.